Thrivent Financial for Lutherans Decreases Holdings in HealthEquity, Inc. $HQY

Thrivent Financial for Lutherans reduced its position in HealthEquity, Inc. (NASDAQ:HQY) by 17.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 282,442 shares of the company’s stock after selling 57,895 shares during the period. Thrivent Financial for Lutherans owned about 0.33% of HealthEquity worth $29,588,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cetera Investment Advisers grew its holdings in HealthEquity by 47.3% in the first quarter. Cetera Investment Advisers now owns 5,260 shares of the company’s stock valued at $465,000 after purchasing an additional 1,688 shares during the last quarter. Russell Investments Group Ltd. boosted its position in shares of HealthEquity by 108.7% in the 1st quarter. Russell Investments Group Ltd. now owns 140,829 shares of the company’s stock worth $12,445,000 after buying an additional 73,358 shares in the last quarter. American Century Companies Inc. grew its stake in HealthEquity by 35.8% in the 1st quarter. American Century Companies Inc. now owns 775,147 shares of the company’s stock valued at $68,500,000 after acquiring an additional 204,195 shares during the last quarter. Cresset Asset Management LLC increased its holdings in HealthEquity by 32.7% during the 1st quarter. Cresset Asset Management LLC now owns 5,347 shares of the company’s stock valued at $473,000 after acquiring an additional 1,317 shares in the last quarter. Finally, Aviso Financial Inc. purchased a new position in HealthEquity during the 1st quarter valued at about $158,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HQY has been the topic of several recent research reports. Jefferies Financial Group upped their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a report on Wednesday, September 3rd. JMP Securities set a $122.00 target price on HealthEquity in a research note on Thursday, December 4th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. JPMorgan Chase & Co. raised their price target on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Finally, KeyCorp reduced their price objective on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $120.27.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total value of $156,840.00. Following the transaction, the executive vice president owned 75,479 shares in the company, valued at $7,892,084.24. This trade represents a 1.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 10,781 shares of company stock worth $1,016,707 over the last three months. Corporate insiders own 1.50% of the company’s stock.

HealthEquity Price Performance

HQY stock opened at $95.75 on Tuesday. The stock has a market capitalization of $8.18 billion, a price-to-earnings ratio of 43.92, a price-to-earnings-growth ratio of 1.40 and a beta of 0.18. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65. The stock’s fifty day simple moving average is $96.86 and its 200-day simple moving average is $96.59.

HealthEquity (NASDAQ:HQY) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same period in the prior year, the business posted $0.78 earnings per share. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.